We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
No events to show.
Consensus vs. actual, and revenue trend
Rating & price-target changes
Stored first · Google News · Yahoo Finance (English)
Park Ha Biological Technology Adopts Cayman Home Country Governance Exemptions on Nasdaq - TipRanks
Park Ha Biological Technology Adopts Cayman Home Country Governance Exemptions on Nasdaq TipRanks
Park Ha Biological Technology adopts Cayman Islands governance exemptions on Nasdaq - Investing.com
Park Ha Biological Technology adopts Cayman Islands governance exemptions on Nasdaq Investing.com
Park Ha Biological Technology (BYAH) Faces Continued Pressure Near Support Levels - Backspread Trade - The Legal Advocate
Park Ha Biological Technology (BYAH) Faces Continued Pressure Near Support Levels - Backspread Trade The Legal Advocate
How Park Ha Bio (BYAH) balances growth with profitability (Leaps) 2026-05-08 - Max Pain Level - The Legal Advocate
How Park Ha Bio (BYAH) balances growth with profitability (Leaps) 2026-05-08 - Max Pain Level The Legal Advocate
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| FY2025 Q2 | 2024. 04. 30. | Time TBD | — | $0 | — | — | $852.93K | Reported |
No research actions to show.
As of FY2025Q2 · Source: SEC/DART + price data
No holdings data to show.